Nurix Therapeutics, Inc. ($NRIX)
Filing Information
| Accession Number | 0001817160-26-000017 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
13,068
Total Value
$117,002.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Aug 5, 2026 | Exercise/Conversion | 4,356 | $1.86 | $8,102.16 | 121,583 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Aug 5, 2026 | Sale | 4,356 | $25.00 | $108,900.00 | 117,227 | Direct | โ | View Details | |
Chief Scientific Officer | Employee Stock Option (right to buy) | Derivative | Aug 5, 2026 | Exercise/Conversion | 4,356 | $0.00 | $0.00 | 62,310 | Direct | โ | View Details |